A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75  years or more with advanced non-small cell lung cancer -TCOG 1101-

ConclusionsThe recommended doses for this combination therapy are carboplatin AUC 5 and S-1 80  mg/m2/day every 3  weeks, and this combination is effective with tolerable toxicities for advanced NSCLC patients ≥ 75 years old.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research